Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Otorhinolaryngology

Free Subscription Articles published in Radiother Oncol Retrieve available abstracts of 226 articles: HTML format

Single Articles

July 2021
1. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
   Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
   Radiother Oncol. 2021 Jul 15. pii: S0167-8140(21)06639.
   PubMed    
   
   
   
2. MUNARETTO TIMM BAIOCCHI J, Fischer-Sgrott F, Baiocchi Neto G
   Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
   Radiother Oncol. 2021 Jul 15. pii: S0167-8140(21)06642.
   PubMed    
   
   
   
3. JO YY, Yu J, Song KJ, Jang JY, et al
   Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: a retrospective study.
   Radiother Oncol. 2021 Jul 12. pii: S0167-8140(21)06643.
   PubMed     Abstract available
   
   
   
4. BOEKHOFF MR, Defize IL, Borggreve AS, van Hillegersberg R, et al
   An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients.
   Radiother Oncol. 2021 Jul 5. pii: S0167-8140(21)06626.
   PubMed     Abstract available
   
   
   
5. VAN DER LAAN HP, van der Schaaf A, Van den Bosch L, Korevaar EW, et al
   Quality of life and toxicity guided treatment plan optimisation for head and neck cancer.
   Radiother Oncol. 2021 Jul 5. pii: S0167-8140(21)06623.
   PubMed     Abstract available
   
   
   June 2021
6. SUN XS, Xie SY, Luo DH, Liu LT, et al
   Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016.
   Radiother Oncol. 2021 Jun 25. pii: S0167-8140(21)06612.
   PubMed     Abstract available
   
   
   
7. DONNELLY O, Goranova R, Nugent M
   Letter to the editor regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" by Robijns et al. Radiat Oncol. 2021.
   Radiother Oncol. 2021 Jun 15. pii: S0167-8140(21)06579.
   PubMed    
   
   
   
8. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
   Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
   Radiother Oncol. 2021 Jun 10. pii: S0167-8140(21)06581.
   PubMed    
   
   
   
9. JIN YN, Yao JJ, You YF, Cao HJ, et al
   Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study.
   Radiother Oncol. 2021 Jun 8. pii: S0167-8140(21)06575.
   PubMed     Abstract available
   
   
   
10. DE BREE R, Swartz JE, Bril S, Chargi N, et al
    Skeletal muscle mass measurements using head and neck CT imaging in head and neck cancer patients.
    Radiother Oncol. 2021 Jun 6. pii: S0167-8140(21)06573.
    PubMed    
    
    
    May 2021
11. JIANG C, Gong B, Gao H, Zhang T, et al
    Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC).
    Radiother Oncol. 2021 May 24. pii: S0167-8140(21)06258.
    PubMed     Abstract available
    
    
    
12. BOEKHOFF MR, Defize IL, Borggreve AS, van Hillegersberg R, et al
    CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis.
    Radiother Oncol. 2021 May 13. pii: S0167-8140(21)06241.
    PubMed     Abstract available
    
    
    
13. WANG XY, Zhu SY, Wu WJ, Li HJ, et al
    Extent of Paranasal Sinus Involvement and its Prognostic Value in Nasopharyngeal Carcinoma: Proposed Modification in the Current UICC/AJCC staging system.
    Radiother Oncol. 2021 May 10. pii: S0167-8140(21)06224.
    PubMed     Abstract available
    
    
    
14. SUN Z, Hu S, Xue Q, Jin L, et al
    Can 3D pseudo-continuous arterial spin labeling perfusion imaging be applied to predict early response to chemoradiotherapy in patients with advanced nasopharyngeal carcinoma?
    Radiother Oncol. 2021 May 2. pii: S0167-8140(21)06214.
    PubMed     Abstract available
    
    
    April 2021
15. TAMBAS M, der Laan HPV, Rutgers W, van den Hoek JGM, et al
    Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy.
    Radiother Oncol. 2021 Apr 20. pii: S0167-8140(21)06194.
    PubMed     Abstract available
    
    
    
16. VAN DER LAAN HP, Van den Bosch L, Schuit E, Steenbakkers RJHM, et al
    aImpact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer.
    Radiother Oncol. 2021 Apr 20. pii: S0167-8140(21)06193.
    PubMed     Abstract available
    
    
    
17. ELICIN O, Koller Brolese E, Bojaxhiu B, Sermaxhaj B, et al
    The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer.
    Radiother Oncol. 2021 Apr 10. pii: S0167-8140(21)06185.
    PubMed     Abstract available
    
    
    
18. ESTEBAN B, Pierre P, Camille S, Pascal P, et al
    Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: a multicentric study using propensity score.
    Radiother Oncol. 2021 Apr 9. pii: S0167-8140(21)06183.
    PubMed     Abstract available
    
    
    
19. LU ZJ, Liu LT, Sun XS, Guo SS, et al
    Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06175.
    PubMed     Abstract available
    
    
    
20. YAN JJ, Guo SS, Lin DF, Liu LT, et al
    Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06180.
    PubMed     Abstract available
    
    
    
21. QIU Y, Guo Z, Lin X, Li J, et al
    Standard radiotherapy for patients with nasopharyngeal carcinoma results in progressive tract-specific brain white matter alterations: A one-year follow-up via diffusion tensor imaging.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06179.
    PubMed     Abstract available
    
    
    
22. ZHANG Y, Feng W, Gao LT, Cai XW, et al
    Long-term follow-up of a phase I/II trial of radiation dose escalation by simultaneous integrated boost for locally advanced esophageal squamous cell carcinoma.
    Radiother Oncol. 2021 Apr 1. pii: S0167-8140(21)06171.
    PubMed     Abstract available
    
    
    
23. WONG ET, Huang SH, O'Sullivan B, Persaud V, et al
    Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.
    Radiother Oncol. 2021;157:255-262.
    PubMed     Abstract available
    
    
    
24. JENSEN GL, Axelrud G, Fink D, Hammonds K, et al
    Improved local control in p16 negative oropharyngeal cancers with hypermethylated MGMT.
    Radiother Oncol. 2021;157:234-240.
    PubMed     Abstract available
    
    
    
25. BAUWENS L, Baltres A, Fiani DJ, Zrounba P, et al
    Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Radiother Oncol. 2021;157:122-129.
    PubMed     Abstract available
    
    
    
26. MEN K, Chen X, Yang B, Zhu J, et al
    Automatic segmentation of three clinical target volumes in radiotherapy using lifelong learning.
    Radiother Oncol. 2021;157:1-7.
    PubMed     Abstract available
    
    
    March 2021
27. LI G, Jiang Y, Li G, Qiao Q, et al
    Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Mar 25. pii: S0167-8140(21)06143.
    PubMed     Abstract available
    
    
    
28. LOSER A, Abel J, Magdalena Kutz L, Krause L, et al
    Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: results from the prospective randomized headnut-trial.
    Radiother Oncol. 2021 Mar 22. pii: S0167-8140(21)06145.
    PubMed     Abstract available
    
    
    
29. RUHLE A, Grosu AL, Wiedenmann N, Stoian R, et al
    Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial.
    Radiother Oncol. 2021 Mar 19. pii: S0167-8140(21)06140.
    PubMed     Abstract available
    
    
    
30. GROSSBERG AJ, Rock CD, Edwards J, Mohamed ASR, et al
    Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy.
    Radiother Oncol. 2021 Mar 15. pii: S0167-8140(21)06131.
    PubMed     Abstract available
    
    
    
31. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
    Radiother Oncol. 2021 Mar 9. pii: S0167-8140(21)06117.
    PubMed     Abstract available
    
    
    
32. CHEN B, Deng M, Yang C, Dragomir MP, et al
    High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06094.
    PubMed     Abstract available
    
    
    
33. BROLESE EK, Cihoric N, Bojaxhiu B, Sermaxhaj B, et al
    The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06113.
    PubMed     Abstract available
    
    
    
34. HOSNI A, Huang SH, Xu W, Su J, et al
    Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma.
    Radiother Oncol. 2021;156:95-101.
    PubMed     Abstract available
    
    
    February 2021
35. HUANG TW, Shao CH, Chiang CC
    Response to the letter to the editor "Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials regards to Chiu et al."
    Radiother Oncol. 2021 Feb 26. pii: S0167-8140(21)06086.
    PubMed    
    
    
    
36. CHIU YH, Wang TG
    Letter to the editor regarding Shao et al., Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials.
    Radiother Oncol. 2021 Feb 26. pii: S0167-8140(21)06088.
    PubMed    
    
    
    
37. FAN WJ, Teng F, Liu G, Zhao DW, et al
    Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Feb 12. pii: S0167-8140(21)06050.
    PubMed     Abstract available
    
    
    
38. NIE D, Wang X, Sun M, Feng Z, et al
    The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: a systematic review and meta-analysis.
    Radiother Oncol. 2021 Feb 12. pii: S0167-8140(21)06047.
    PubMed     Abstract available
    
    
    
39. YANG ES, Deutsch E, Mehmet A, Fayette J, et al
    A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Feb 9. pii: S0167-8140(21)06040.
    PubMed     Abstract available
    
    
    
40. VAN AKEN ESM, Paul van der Laan H, Bijl HP, Van den Bosch L, et al
    Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)06023.
    PubMed     Abstract available
    
    
    
41. VAN DEN BOSCH L, van der Schaaf A, Paul van der Laan H, Hoebers FJP, et al
    Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)06021.
    PubMed     Abstract available
    
    
    
42. MICHAELIDOU A, Adjogatse D, Suh Y, Pike L, et al
    18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO).
    Radiother Oncol. 2021;155:261-268.
    PubMed     Abstract available
    
    
    
43. ROSEN BS, Wilkie JR, Sun Y, Ibrahim M, et al
    CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Radiother Oncol. 2021;155:174-181.
    PubMed     Abstract available
    
    
    January 2021
44. MAO Y, Wang S, Lydiatt W, Shah JP, et al
    Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems.
    Radiother Oncol. 2021 Jan 28. pii: S0167-8140(21)00015.
    PubMed     Abstract available
    
    
    
45. LACAS B, Carmel A, Landais C, Wong SJ, et al
    Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.
    Radiother Oncol. 2021 Jan 27. pii: S0167-8140(21)00013.
    PubMed     Abstract available
    
    
    
46. WEN DW, Lin L, Mao YP, Chen CY, et al
    Comparison of Normal Tissue Complication Probability (NTCP) Models Using Machine Learning for Predicting Temporal Lobe Injury after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: a Large Registry-Based Retrospective Study from China.
    Radiother Oncol. 2021 Jan 20. pii: S0167-8140(21)00008.
    PubMed     Abstract available
    
    
    
47. HUANG TT, Li SH, Chen YH, Lu HI, et al
    Definitive chemoradiotherapy for clinical T4b esophageal cancer - treatment outcomes, failure patterns, and prognostic factors.
    Radiother Oncol. 2021 Jan 19. pii: S0167-8140(21)00007.
    PubMed     Abstract available
    
    
    
48. GUO Q, Zheng Y, Lin J, Xu Y, et al
    Modified Reduced-volume Intensity-modulated radiation therapy in Non-metastatic Nasopharyngeal Carcinoma: A Prospective Observation Series.
    Radiother Oncol. 2021 Jan 5. pii: S0167-8140(20)31262.
    PubMed     Abstract available
    
    
    
49. QIU X, Xu T, Li M, Fei Z, et al
    Response to Chai' letter: What caused the difference in prognosis among different physicians?
    Radiother Oncol. 2021;154:e20-e21.
    PubMed    
    
    
    December 2020
50. 
    Salivary glands at the pharyngeal ostium of the Eustachian tube are already described in histological literature.
    Radiother Oncol. 2020 Dec 30. pii: S0167-8140(20)31248.
    PubMed    
    
    
    
51. FAN KH, Yeh CH, Hung SP, Kang CJ, et al
    Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation.
    Radiother Oncol. 2020 Dec 29. pii: S0167-8140(20)31255.
    PubMed     Abstract available
    
    
    
52. XIANG M, Gensheimer MF, Pollom EL, Holsinger FC, et al
    Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.
    Radiother Oncol. 2020 Dec 28. pii: S0167-8140(20)31251.
    PubMed     Abstract available
    
    
    
53. LIANG SB, Chen LS, Chen HY, Yang XL, et al
    Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: a retrospective study.
    Radiother Oncol. 2020 Dec 10. pii: S0167-8140(20)31231.
    PubMed     Abstract available
    
    
    November 2020
54. RUHLE A, Stromberger C, Haehl E, Senger C, et al
    Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
    Radiother Oncol. 2020 Nov 24. pii: S0167-8140(20)31193.
    PubMed     Abstract available
    
    
    
55. LIANG SB, Chen LS, Yang XL, Chen DM, et al
    Influence of Tumor Necrosis on Treatment Sensitivity and Long-term Survival in Nasopharyngeal Carcinoma.
    Radiother Oncol. 2020 Nov 17. pii: S0167-8140(20)31165.
    PubMed     Abstract available
    
    
    
56. HIROSE K, Konno A, Hiratsuka J, Yoshimoto S, et al
    Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan((10)B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial.
    Radiother Oncol. 2020 Nov 10. pii: S0167-8140(20)30890.
    PubMed     Abstract available
    
    
    
57. YANG HC, Wu CC, Lee CC, Huang HE, et al
    Prediction of Pseudoprogression and Long-term Outcome of Vestibular Schwannoma after Gamma Knife Radiosurgery based on Preradiosurgical MR Radiomics.
    Radiother Oncol. 2020 Nov 5. pii: S0167-8140(20)30888.
    PubMed     Abstract available
    
    
    October 2020
58. CHEN NB, Li QW, Li S, Guo SP, et al
    Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: a phase I trial (GASTO-1021).
    Radiother Oncol. 2020 Oct 31. pii: S0167-8140(20)30882.
    PubMed     Abstract available
    
    
    
59. ZSCHAECK S, Zophel K, Seidlitz A, Zips D, et al
    Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
    Radiother Oncol. 2020;155:204-211.
    PubMed     Abstract available
    
    
    
60. VAN ROSSUM PSN, Jeene PM, Rozema T, Braam PM, et al
    Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: a matched comparison of two prospective trials.
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30845.
    PubMed     Abstract available
    
    
    
61. LUO WJ, Zou WQ, Liang SB, Chen L, et al
    Combining tumor response and personalized risk assessment: potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Radiother Oncol. 2020 Oct 8. pii: S0167-8140(20)30841.
    PubMed     Abstract available
    
    
    
62. HAMILTON SN, Urban R, Liu A, Chau N, et al
    Population-based outcomes by immunosuppressed status in patients undergoing radiotherapy for oropharyngeal cancer.
    Radiother Oncol. 2020;151:110-117.
    PubMed     Abstract available
    
    
    
63. LAI TY, Yeh CM, Hu YW, Liu CJ, et al
    Hospital volume and physician volume in association with survival in patients with nasopharyngeal cancer after radiation therapy.
    Radiother Oncol. 2020;151:190-199.
    PubMed     Abstract available
    
    
    
64. SHARMA MB, Jensen K, Urbak SF, Funding M, et al
    A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer.
    Radiother Oncol. 2020;151:58-65.
    PubMed     Abstract available
    
    
    September 2020
65. LI J, Wen Y, Xiang Z, Du H, et al
    Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer.
    Radiother Oncol. 2020 Sep 24. pii: S0167-8140(20)30817.
    PubMed     Abstract available
    
    
    
66. LIN CH, Chou WC, Wu YY, Lin CY, et al
    Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study.
    Radiother Oncol. 2020 Sep 14. pii: S0167-8140(20)30784.
    PubMed     Abstract available
    
    
    
67. GARCIA-CONSUEGRA A, Gimeno Morales M, Cambeiro M, Tagliaferri L, et al
    Dose Volume Histogram Constraints in Patients with Head and Neck Cancer treated with Surgery and Adjuvant HDR Brachytherapy: A Proposal of the Head and Neck and Skin GEC ESTRO Working Group.
    Radiother Oncol. 2020 Sep 14. pii: S0167-8140(20)30787.
    PubMed     Abstract available
    
    
    
68. HU Y, Xie C, Yang H, Wk Ho J, et al
    Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
    Radiother Oncol. 2020 Sep 14. pii: S0167-8140(20)30786.
    PubMed     Abstract available
    
    
    
69. LE GUEVELOU J, Bastit V, Marcy PY, Lasne-Cardon A, et al
    Flap Delineation Guidelines in Postoperative Head and Neck Radiation Therapy for head and neck cancers.
    Radiother Oncol. 2020 Sep 2. pii: S0167-8140(20)30754.
    PubMed     Abstract available
    
    
    
70. DAHELE M, Tol JP, Vergeer MR, Jansen F, et al
    Is the introduction of more advanced radiotherapy techniques for locally-advanced head and neck cancer associated with improved quality of life and reduced symptom burden?
    Radiother Oncol. 2020 Sep 2. pii: S0167-8140(20)30755.
    PubMed     Abstract available
    
    
    
71. SHAO CH, Chiang CC, Huang TW
    Exercise therapy for cancer therapy-induced trismus in patients with head and neck cancer: a systematic review and meta-analysis of randomized controlled trials.
    Radiother Oncol. 2020 Sep 2. pii: S0167-8140(20)30753.
    PubMed     Abstract available
    
    
    August 2020
72. XU C, Zhang Y, Chen L, Li WF, et al
    Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006-2016.
    Radiother Oncol. 2020 Aug 28. pii: S0167-8140(20)30737.
    PubMed     Abstract available
    
    
    
73. KANAYAMA N, Otozai S, Yoshii T, Toratani M, et al
    Death unrelated to cancer and death from aspiration pneumonia after definitive radiotherapy for head and neck cancer.
    Radiother Oncol. 2020 Aug 28. pii: S0167-8140(20)30733.
    PubMed     Abstract available
    
    
    
74. SAKSO M, Mortensen LS, Primdahl H, Johansen J, et al
    Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).
    Radiother Oncol. 2020 Aug 14. pii: S0167-8140(20)30724.
    PubMed     Abstract available
    
    
    
75. DANIELS CP, Yu-Hao Liu H, Bernard A, Williams C, et al
    The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer.
    Radiother Oncol. 2020 Aug 13. pii: S0167-8140(20)30722.
    PubMed     Abstract available
    
    
    
76. JENSEN K, Friborg J, Hansen CR, Samsoe E, et al
    The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines.
    Radiother Oncol. 2020 Aug 8. pii: S0167-8140(20)30685.
    PubMed    
    
    
    
77. TAMBAS M, J H M Steenbakkers R, van der Laan HP, Wolters AM, et al
    First experience with model-based selection of head and neck cancer patients for proton therapy.
    Radiother Oncol. 2020 Aug 5. pii: S0167-8140(20)30715.
    PubMed     Abstract available
    
    
    July 2020
78. THOMSON DJ, Palma D, Guckenberger M, Balermpas P, et al
    Reprint of: Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement.
    Radiother Oncol. 2020 Jul 27. pii: S0167-8140(20)30200.
    PubMed     Abstract available
    
    
    
79. HILKE FJ, Muyas F, Admard J, Kootz B, et al
    Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy.
    Radiother Oncol. 2020 Jul 17. pii: S0167-8140(20)30421.
    PubMed     Abstract available
    
    
    
80. MA H, Liang S, Cui C, Zhang Y, et al
    Prognostic significance of quantitative metastatic lymph node burden on magnetic resonance imaging in nasopharyngeal carcinoma:a retrospective study of 1224 patients from two centers.
    Radiother Oncol. 2020 Jul 14. pii: S0167-8140(20)30416.
    PubMed     Abstract available
    
    
    
81. HONG RIM C
    Letter to the editor regarding the article "Selection of a high-level physician may help improve outcomes of nasopharyngeal carcinoma" by Fei et al.
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30413.
    PubMed    
    
    
    
82. CELLINI F, Antonietta Gambacorta M, Carlo Mattiucci G, Valentini V, et al
    Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond.
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30398.
    PubMed    
    
    
    
83. TCHELEBI LT, Goodman K
    Response to, "Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond".
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30404.
    PubMed    
    
    
    
84. ZHONG LZ, Fang XL, Dong D, Peng H, et al
    A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0.
    Radiother Oncol. 2020 Jul 4. pii: S0167-8140(20)30387.
    PubMed     Abstract available
    
    
    
85. PENG Y, Chen S, Qin A, Chen M, et al
    Magnetic resonance-based synthetic computed tomography images generated using generative adversarial networks for nasopharyngeal carcinoma radiotherapy treatment planning.
    Radiother Oncol. 2020 Jul 2. pii: S0167-8140(20)30385.
    PubMed     Abstract available
    
    
    
86. WENTZEL A, Hanula P, van Dijk LV, Elgohari B, et al
    Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy.
    Radiother Oncol. 2020;148:245-251.
    PubMed     Abstract available
    
    
    
87. GRANT SR, Hutcheson KA, Ye R, Garden AS, et al
    Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
    Radiother Oncol. 2020;148:133-139.
    PubMed     Abstract available
    
    
    June 2020
88. SHAHID IQBAL M, Kovarik J, Kelly C
    Challenges in conducting large randomised control trials of palliative radiotherapy in head and neck cancer.
    Radiother Oncol. 2020 Jun 27. pii: S0167-8140(20)30351.
    PubMed    
    
    
    
89. RULACH R, Zhou S, Paterson C
    Letter to editor regarding Urban et al., FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status.
    Radiother Oncol. 2020 Jun 24. pii: S0167-8140(20)30357.
    PubMed    
    
    
    
90. JIN J, Guo Y, Dong X, Liu J, et al
    Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency.
    Radiother Oncol. 2020 Jun 21. pii: S0167-8140(20)30347.
    PubMed     Abstract available
    
    
    
91. WIEDENMANN N, Grosu AL, Buchert M, Rischke HC, et al
    The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
    Radiother Oncol. 2020 Jun 13. pii: S0167-8140(20)30336.
    PubMed     Abstract available
    
    
    
92. LAN X, Chan JYK, Pu JJ, Qiao W, et al
    Saliva electrolyte analysis and xerostomia-related quality of life in nasopharyngeal carcinoma patients following intensity-modulated radiation therapy.
    Radiother Oncol. 2020 Jun 13. pii: S0167-8140(20)30339.
    PubMed     Abstract available
    
    
    
93. RIESTERER O, Pruschy M, Bender S, Sharma A, et al
    Consolidation cetuximab after concurrent triplet radiochemotherapy + cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
    Radiother Oncol. 2020 Jun 12. pii: S0167-8140(20)30334.
    PubMed     Abstract available
    
    
    
94. MANZAR GS, Lester SC, Routman DM, Harmsen WS, et al
    Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.
    Radiother Oncol. 2020;147:64-74.
    PubMed     Abstract available
    
    
    May 2020
95. LAN K, Zhu J, Zhang J, Zhou S, et al
    Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy.
    Radiother Oncol. 2020 May 28. pii: S0167-8140(20)30292.
    PubMed     Abstract available
    
    
    
96. SO TH, Lam KO
    The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy: Asian perspectives in the immunotherapy era.
    Radiother Oncol. 2020 May 19. pii: S0167-8140(20)30281.
    PubMed    
    
    
    
97. TINUSZ B, Soos A, Hegyi P, Sarlos P, et al
    Efficacy and safety of stenting and additional oncological treatment versus stenting alone in unresectable esophageal cancer: a meta-analysis and systematic review.
    Radiother Oncol. 2020 May 15. pii: S0167-8140(20)30268.
    PubMed     Abstract available
    
    
    
98. ZSCHAECK S, Lock S, Hofheinz F, Zips D, et al
    Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy.
    Radiother Oncol. 2020 May 14. pii: S0167-8140(20)30275.
    PubMed     Abstract available
    
    
    
99. TAO Y, Auperin A, Blanchard P, Alfonsi M, et al
    Concurrent cisplatin and Dose escalation with Intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
    Radiother Oncol. 2020 May 14. pii: S0167-8140(20)30274.
    PubMed     Abstract available
    
    
    
100. AL-MAMGANI A, Kessels R, Verhoef CG, Navran A, et al
     Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma.
     Radiother Oncol. 2020 May 14. pii: S0167-8140(20)30273.
     PubMed     Abstract available
     
     
     April 2020
101. ANDERSON JL, Newman NB, Anderson C, Sherry AD, et al
     Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer.
     Radiother Oncol. 2020 Apr 11. pii: S0167-8140(19)33508.
     PubMed     Abstract available
     
     
     
102. ZHOU S, Huang H, Chen Q, Tan KS, et al
     Long-term defects of nasal epithelium barrier functions in patients with nasopharyngeal carcinoma post chemo-radiotherapy.
     Radiother Oncol. 2020;148:116-125.
     PubMed     Abstract available
     
     
     
103. VAN RIJN-DEKKER MI, van den Bosch L, van den Hoek JGM, Bijl HP, et al
     Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy.
     Radiother Oncol. 2020;147:103-110.
     PubMed     Abstract available
     
     
     
104. URBAN R, Godoy T, Olson R, Wu J, et al
     FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status.
     Radiother Oncol. 2020;148:14-20.
     PubMed     Abstract available
     
     
     
105. DE FELICE F, Bird T, Michaelidou A, Thavaraj S, et al
     Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems.
     Radiother Oncol. 2020;145:146-153.
     PubMed     Abstract available
     
     
     
106. NG SP, Bahig H, Jethanandani A, Pollard C, et al
     Lymphopenia during radiotherapy in patients with oropharyngeal cancer.
     Radiother Oncol. 2020;145:95-100.
     PubMed     Abstract available
     
     
     March 2020
107. DE VEIJ MESTDAGH PD, Walraven I, Vogel WV, Schreuder WH, et al
     SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach.
     Radiother Oncol. 2020;147:56-63.
     PubMed     Abstract available
     
     
     
108. FEI Z, Qiu X, Li Y, Huang Y, et al
     Selection of a high-level physician may help improve outcomes of nasopharyngeal carcinoma.
     Radiother Oncol. 2020;147:130-135.
     PubMed     Abstract available
     
     
     
109. BOEKHOFF MR, Defize IL, Borggreve AS, Takahashi N, et al
     3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy.
     Radiother Oncol. 2020;147:1-7.
     PubMed     Abstract available
     
     
     
110. BEDDOK A, Vela A, Calugaru V, Tessonnier T, et al
     Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges.
     Radiother Oncol. 2020;147:30-39.
     PubMed     Abstract available
     
     
     
111. DE FELICE F, Polimeni A, Valentini V
     The impact of Coronavirus (COVID-19) on head and neck cancer patients' care.
     Radiother Oncol. 2020;147:84-85.
     PubMed    
     
     
     
112. XU C, Jin JY, Zhang M, Liu A, et al
     The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy.
     Radiother Oncol. 2020;146:180-186.
     PubMed     Abstract available
     
     
     
113. SHARABIANI M, Clementel E, Andratschke N, Hurkmans C, et al
     Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria.
     Radiother Oncol. 2020;146:143-150.
     PubMed     Abstract available
     
     
     
114. HUANG SH, O'Sullivan B, Su J, Bartlett E, et al
     Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
     Radiother Oncol. 2020;144:13-22.
     PubMed     Abstract available
     
     
     February 2020
115. ZHAI TT, Langendijk JA, van Dijk LV, van der Schaaf A, et al
     Pre-treatment radiomic features predict individual lymph node failure for head and neck cancer patients.
     Radiother Oncol. 2020;146:58-65.
     PubMed     Abstract available
     
     
     
116. FIETKAU R, Hecht M, Hofner B, Lubgan D, et al
     Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial.
     Radiother Oncol. 2020;144:209-217.
     PubMed     Abstract available
     
     
     
117. SARAH D, Daan N, Frederic D, Jean-Francois D, et al
     Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome.
     Radiother Oncol. 2020 Feb 7. pii: S0167-8140(20)30017.
     PubMed     Abstract available
     
     
     January 2020
118. LI WZ, Liu GY, Lin LF, Lv SH, et al
     MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
     Radiother Oncol. 2020;145:101-108.
     PubMed     Abstract available
     
     
     
119. NIYAZI M, Niemierko A, Paganetti H, Sohn M, et al
     Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.
     Radiother Oncol. 2020;142:154-161.
     PubMed     Abstract available
     
     
     
120. IYIZOBA-EBOZUE Z, Murray LJ, Arunsingh M, Vaidyanathan S, et al
     Incidence and patterns of retropharyngeal lymph node involvement in oropharyngeal carcinoma.
     Radiother Oncol. 2020;142:92-99.
     PubMed     Abstract available
     
     
     
121. BAGLEY AF, Ye R, Garden AS, Gunn GB, et al
     Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy.
     Radiother Oncol. 2020;142:133-139.
     PubMed     Abstract available
     
     
     November 2019
122. BHATTACHARYYA T, Koto M, Ikawa H, Hayashi K, et al
     Assessment of risk factors associated with development of oronasal fistula as a late complication after carbon-ion radiotherapy for head and neck cancer.
     Radiother Oncol. 2019;144:53-58.
     PubMed     Abstract available
     
     
     October 2019
123. LEE JY, Kim YA, Kim HS, Back JH, et al
     Radiotherapy can increase the risk of ischemic cerebrovascular disease in head and neck cancer patients: A Korean population-based cohort study.
     Radiother Oncol. 2019 Oct 17. pii: S0167-8140(19)33114.
     PubMed     Abstract available
     
     
     September 2019
124. YANG Z, Zhang X, Wang X, Zhu XR, et al
     Multiple-CT optimization: An adaptive optimization method to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers.
     Radiother Oncol. 2019 Sep 26. pii: S0167-8140(19)33094.
     PubMed     Abstract available
     
     
     
125. ELBERS JBW, Al-Mamgani A, Tesseslaar MET, van den Brekel MWM, et al
     Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial.
     Radiother Oncol. 2019 Sep 26. pii: S0167-8140(19)33046.
     PubMed     Abstract available
     
     
     
126. WANG J, Qing G, Ou X, Hu W, et al
     The impact of target dosimetry on patients' locoregional recurrence in nasopharyngeal carcinoma: A propensity score-matched analysis.
     Radiother Oncol. 2019 Sep 20. pii: S0167-8140(19)33074.
     PubMed     Abstract available
     
     
     August 2019
127. CHAN RJ, Blades R, Jones L, Downer TR, et al
     A single-blind, randomised controlled trial of StrataXRT(R) - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer.
     Radiother Oncol. 2019 Aug 21. pii: S0167-8140(19)33004.
     PubMed     Abstract available
     
     
     
128. KUBO N, Kubota Y, Kawamura H, Oike T, et al
     Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma.
     Radiother Oncol. 2019 Aug 19. pii: S0167-8140(19)33015.
     PubMed     Abstract available
     
     
     
129. VAN DEN BOSCH S, Doornaert PAH, Dijkema T, Zwijnenburg EM, et al
     (18)F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival.
     Radiother Oncol. 2019 Aug 19. pii: S0167-8140(19)33018.
     PubMed     Abstract available
     
     
     
130. HEUKELOM J, Kantor ME, Mohamed ASR, Elhalawani H, et al
     Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.
     Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33027.
     PubMed     Abstract available
     
     
     
131. ZHAN M, Zheng H, Yang Y, Xu T, et al
     Cost-effectiveness analysis of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced esophageal squamous cell carcinoma based on the NEOCRTEC5010 trial.
     Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33024.
     PubMed     Abstract available
     
     
     
132. RADES D, Narvaez CA, Splettstosser L, Domer C, et al
     A randomized trial (RAREST-01) comparing Mepitel(R) Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN).
     Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33016.
     PubMed     Abstract available
     
     
     July 2019
133. YU S, Zhang W, Ni W, Xiao Z, et al
     A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
     Radiother Oncol. 2019;140:159-166.
     PubMed     Abstract available
     
     
     June 2019
134. CHOW JCH, Cheung KM, Au KH, Zee BCY, et al
     Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
     Radiother Oncol. 2019;138:93-98.
     PubMed     Abstract available
     
     
     
135. HUANG L, Zhang Y, Liu Y, Li H, et al
     Prognostic value of retropharyngeal lymph node metastasis laterality in nasopharyngeal carcinoma and a proposed modification to the UICC/AJCC N staging system.
     Radiother Oncol. 2019;140:90-97.
     PubMed     Abstract available
     
     
     
136. MOAN JM, Amdal CD, Malinen E, Svestad JG, et al
     The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
     Radiother Oncol. 2019;140:54-61.
     PubMed     Abstract available
     
     
     
137. BATES JE, Morris CG, Hitchcock KE, Dziegielewski PT, et al
     Locally advanced hypopharyngeal and laryngeal cancer: Influence of HPV status.
     Radiother Oncol. 2019;140:6-9.
     PubMed     Abstract available
     
     
     May 2019
138. VAN DER VEEN J, Willems S, Deschuymer S, Robben D, et al
     Benefits of deep learning for delineation of organs at risk in head and neck cancer.
     Radiother Oncol. 2019;138:68-74.
     PubMed     Abstract available
     
     
     
139. WILKIE JR, Mierzwa ML, Yao J, Eisbruch A, et al
     Big data analysis of associations between patient reported outcomes, observer reported toxicities, and overall quality of life in head and neck cancer patients treated with radiation therapy.
     Radiother Oncol. 2019;137:167-174.
     PubMed     Abstract available
     
     
     
140. KOIVUNORO H, Kankaanranta L, Seppala T, Haapaniemi A, et al
     Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival.
     Radiother Oncol. 2019;137:153-158.
     PubMed     Abstract available
     
     
     
141. YAO JJ, Qi ZY, Liu ZG, Jiang GM, et al
     Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
     Radiother Oncol. 2019;137:137-144.
     PubMed     Abstract available
     
     
     
142. GANJU RG, Morse R, Hoover A, TenNapel M, et al
     The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
     Radiother Oncol. 2019;137:117-124.
     PubMed     Abstract available
     
     
     
143. LIU SL, Sun XS, Yan JJ, Chen QY, et al
     Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.
     Radiother Oncol. 2019;137:83-94.
     PubMed     Abstract available
     
     
     
144. BRENNER B, Purim O, Gordon N, Goshen-Lago T, et al
     The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial.
     Radiother Oncol. 2019;134:74-80.
     PubMed     Abstract available
     
     
     
145. LI HJ, Hu YY, Huang L, Zhou J, et al
     Subclassification of skull-base invasion for nasopharyngeal carcinoma using cluster, network and survival analyses: A double-center retrospective investigation.
     Radiother Oncol. 2019;134:37-43.
     PubMed     Abstract available
     
     
     
146. GABANI P, Lin AJ, Barnes J, Oppelt P, et al
     Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
     Radiother Oncol. 2019;134:81-88.
     PubMed     Abstract available
     
     
     April 2019
147. VAN DER VEEN J, Gulyban A, Nuyts S
     Interobserver variability in delineation of target volumes in head and neck cancer.
     Radiother Oncol. 2019;137:9-15.
     PubMed     Abstract available
     
     
     
148. MENECEUR S, Lock S, Gudziol V, Hering S, et al
     Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.
     Radiother Oncol. 2019;137:24-31.
     PubMed     Abstract available
     
     
     
149. ZHUO X, Huang X, Yan M, Li H, et al
     Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
     Radiother Oncol. 2019;137:16-23.
     PubMed     Abstract available
     
     
     
150. HAYASHI K, Koto M, Ikawa H, Hagiwara Y, et al
     Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy.
     Radiother Oncol. 2019;136:148-153.
     PubMed     Abstract available
     
     
     
151. WAGENAAR D, Kierkels RGJ, Free J, Langendijk JA, et al
     Composite minimax robust optimization of VMAT improves target coverage and reduces non-target dose in head and neck cancer patients.
     Radiother Oncol. 2019;136:71-77.
     PubMed     Abstract available
     
     
     
152. DENG W, Xu C, Liu A, van Rossum PSN, et al
     The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
     Radiother Oncol. 2019;133:9-15.
     PubMed     Abstract available
     
     
     
153. CHO WK, Oh D, Kim HK, Ahn YC, et al
     Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery.
     Radiother Oncol. 2019;133:87-92.
     PubMed     Abstract available
     
     
     
154. LIAO W, Zheng Y, Bi S, Zhang B, et al
     Carotid stenosis prevalence after radiotherapy in nasopharyngeal carcinoma: A meta-analysis.
     Radiother Oncol. 2019;133:167-175.
     PubMed     Abstract available
     
     
     
155. 
     Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating.
     Radiother Oncol. 2019;133:35-42.
     PubMed     Abstract available
     
     
     March 2019
156. KOSMIN M, Ledsam J, Romera-Paredes B, Mendes R, et al
     Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer.
     Radiother Oncol. 2019;135:130-140.
     PubMed     Abstract available
     
     
     
157. SMITH J, Nastasi D, Tso R, Vangaveti V, et al
     The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis.
     Radiother Oncol. 2019;135:51-57.
     PubMed     Abstract available
     
     
     
158. REID P, Marcu LG, Olver I, Moghaddasi L, et al
     Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response.
     Radiother Oncol. 2019;135:1-12.
     PubMed     Abstract available
     
     
     
159. CAI J, Cheng J, Li H, Lin WJ, et al
     A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
     Radiother Oncol. 2019;132:34-41.
     PubMed     Abstract available
     
     
     February 2019
160. WAN Y, Tian L, Zhang G, Xin H, et al
     The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
     Radiother Oncol. 2019;131:35-44.
     PubMed     Abstract available
     
     
     
161. MCDOWELL LJ, Ringash J, Xu W, Chan B, et al
     A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy.
     Radiother Oncol. 2019;131:179-185.
     PubMed     Abstract available
     
     
     January 2019
162. GAWRYSZUK A, Bijl HP, Holwerda M, Halmos GB, et al
     Functional Swallowing Units (FSUs) as organs-at-risk for radiotherapy. PART 2: Advanced delineation guidelines for FSUs.
     Radiother Oncol. 2019;130:68-74.
     PubMed     Abstract available
     
     
     
163. GAWRYSZUK A, Bijl HP, Holwerda M, Halmos GB, et al
     Functional Swallowing Units (FSUs) as organs-at-risk for radiotherapy. PART 1: Physiology and anatomy.
     Radiother Oncol. 2019;130:62-67.
     PubMed     Abstract available
     
     
     
164. 
     A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findi
     Radiother Oncol. 2019;130:46-55.
     PubMed     Abstract available
     
     
     November 2018
165. YAO JJ, Zhang F, Gao TS, Zhang WJ, et al
     Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
     Radiother Oncol. 2018 Nov 14. pii: S0167-8140(18)33542.
     PubMed     Abstract available
     
     
     
166. TOPKAN E, Yildirim BA
     Epoetin receptor status may alter the outcomes in head and neck cancers treated with radiotherapy and darbepoetin-alpha.
     Radiother Oncol. 2018 Nov 7. pii: S0167-8140(18)33397.
     PubMed    
     
     
     October 2018
167. LIANG SB, Zhang N, Chen DM, Yang XL, et al
     Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
     Radiother Oncol. 2018 Oct 23. pii: S0167-8140(18)33522.
     PubMed     Abstract available
     
     
     
168. YILMAZ MT, Elmali A, Yazici G
     Comments on "High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer".
     Radiother Oncol. 2018 Oct 17. pii: S0167-8140(18)33506.
     PubMed    
     
     
     
169. KANAYAMA N, Kierkels RGJ, van der Schaaf A, Steenbakkers RJHM, et al
     External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6months after definitive radiotherapy for head and neck cancer.
     Radiother Oncol. 2018 Oct 6. pii: S0167-8140(18)33496.
     PubMed     Abstract available
     
     
     September 2018
170. HUANG XD, Zhou GQ, Lv JW, Zhou HQ, et al
     Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis.
     Radiother Oncol. 2018 Sep 27. pii: S0167-8140(18)33487.
     PubMed     Abstract available
     
     
     
171. OVERGAARD J, Alsner J
     Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC).
     Radiother Oncol. 2018 Sep 21. pii: S0167-8140(18)33452.
     PubMed    
     
     
     
172. BIAU J, Dunet V, Lapeyre M, Simon C, et al
     Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers.
     Radiother Oncol. 2018 Sep 8. pii: S0167-8140(18)33458.
     PubMed     Abstract available
     
     
     
173. KAMAL M, Mohamed ASR, Volpe S, Zaveri J, et al
     Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
     Radiother Oncol. 2018;128:442-451.
     PubMed     Abstract available
     
     
     
174. DIXON L, Ramasamy S, Cardale K, Dyker K, et al
     Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
     Radiother Oncol. 2018;128:452-458.
     PubMed     Abstract available
     
     
     August 2018
175. OU D, Adam J, Garberis I, Blanchard P, et al
     Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy.
     Radiother Oncol. 2018 Aug 29. pii: S0167-8140(18)33451.
     PubMed     Abstract available
     
     
     
176. DE VEIJ MESTDAGH PD, Janssen T, Lamers E, Carbaat C, et al
     SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
     Radiother Oncol. 2018 Aug 4. pii: S0167-8140(18)33422.
     PubMed     Abstract available
     
     
     
177. LEGER S, Zwanenburg A, Pilz K, Zschaeck S, et al
     CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer.
     Radiother Oncol. 2018 Aug 4. pii: S0167-8140(18)33419.
     PubMed     Abstract available
     
     
     
178. LI YJ, Luo Y, Xie XQ, Li P, et al
     The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.
     Radiother Oncol. 2018 Aug 3. pii: S0167-8140(18)33421.
     PubMed     Abstract available
     
     
     July 2018
179. NOBLE DJ, Yeap PL, Seah SYK, Harrison K, et al
     Anatomical change during radiotherapy for head and neck cancer, and its effect on delivered dose to the spinal cord.
     Radiother Oncol. 2018 Jul 23. pii: S0167-8140(18)33396.
     PubMed     Abstract available
     
     
     
180. VAN DEN BOSCH S, Dijkema T, Philippens MEP, Terhaard CHJ, et al
     Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of (18)F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting.
     Radiother Oncol. 2018 Jul 10. pii: S0167-8140(18)33352.
     PubMed     Abstract available
     
     
     
181. NAVRAN A, Heemsbergen W, Janssen T, Hamming-Vrieze O, et al
     The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT).
     Radiother Oncol. 2018 Jul 10. pii: S0167-8140(18)33347.
     PubMed     Abstract available
     
     
     May 2018
182. TAO Y, Faivre L, Laprie A, Boisselier P, et al
     Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.
     Radiother Oncol. 2018 May 18. pii: S0167-8140(18)30246.
     PubMed     Abstract available
     
     
     
183. WINTER RM, Leibfarth S, Schmidt H, Zwirner K, et al
     Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients.
     Radiother Oncol. 2018 May 7. pii: S0167-8140(18)30209.
     PubMed     Abstract available
     
     
     
184. MICHIELS S, Poels K, Crijns W, Delombaerde L, et al
     Volumetric modulated arc therapy of head-and-neck cancer on a fast-rotating O-ring linac: Plan quality and delivery time comparison with a C-arm linac.
     Radiother Oncol. 2018 May 5. pii: S0167-8140(18)30212.
     PubMed     Abstract available
     
     
     
185. VAN DEN BOSCH S, Vogel WV, Raaijmakers CP, Dijkema T, et al
     Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.
     Radiother Oncol. 2018 May 3. pii: S0167-8140(18)30211.
     PubMed     Abstract available
     
     
     
186. DELANEY AR, Dahele M, Slotman BJ, Verbakel WFAR, et al
     Is accurate contouring of salivary and swallowing structures necessary to spare them in head and neck VMAT plans?
     Radiother Oncol. 2018;127:190-196.
     PubMed     Abstract available
     
     
     April 2018
187. MURTHY V, Lewis S, Kannan S, Khadanga CR, et al
     Submandibular function recovery after IMRT in head and neck cancer: A prospective dose modelling study.
     Radiother Oncol. 2018 Apr 30. pii: S0167-8140(18)30113.
     PubMed     Abstract available
     
     
     
188. GREGOIRE V, Grau C
     In reply to "A Long-Awaited Guideline for the Delineation of Primary Tumor in Head and Neck Cancer, and a Few Concerns about It" by Sezin Yuce Sari et al.
     Radiother Oncol. 2018 Apr 27. pii: S0167-8140(18)30175.
     PubMed    
     
     
     
189. YUCE SARI S, Yeginer M, Cengiz M
     A long-awaited guideline for the delineation of primary tumor in head and neck cancer, and a few concerns about it.
     Radiother Oncol. 2018 Apr 24. pii: S0167-8140(18)30177.
     PubMed    
     
     
     March 2018
190. TAN TH, Soon YY, Cheo T, Ho F, et al
     Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis.
     Radiother Oncol. 2018 Mar 16. pii: S0167-8140(18)30123.
     PubMed     Abstract available
     
     
     
191. SHURYAK I, Hall EJ, Brenner DJ
     Dose dependence of accelerated repopulation in head and neck cancer: Supporting evidence and clinical implications.
     Radiother Oncol. 2018 Mar 10. pii: S0167-8140(18)30098.
     PubMed     Abstract available
     
     
     
192. FANG P, Jiang W, Davuluri R, Xu C, et al
     High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer.
     Radiother Oncol. 2018 Mar 9. pii: S0167-8140(18)30117.
     PubMed     Abstract available
     
     
     
193. OVERGAARD J, Hoff CM, Hansen HS, Specht L, et al
     DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
     Radiother Oncol. 2018 Mar 6. pii: S0167-8140(18)30105.
     PubMed     Abstract available
     
     
     
194. HE J, Cai L, Chen Y, He Y, et al
     Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.
     Radiother Oncol. 2018 Mar 5. pii: S0167-8140(18)30063.
     PubMed     Abstract available
     
     
     January 2018
195. IQBAL MS, Kelly C, Kovarik J, Goranov B, et al
     Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A survey of UK national practice.
     Radiother Oncol. 2018 Jan 20. pii: S0167-8140(17)32734.
     PubMed    
     
     
     
196. SHAHID IQBAL M, Kelly C, Kovarik J, Goranov B, et al
     Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review.
     Radiother Oncol. 2018 Jan 19. pii: S0167-8140(17)32766.
     PubMed     Abstract available
     
     
     
197. PAULINO AC, Mahajan A, Ye R, Grosshans DR, et al
     Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
     Radiother Oncol. 2018 Jan 17. pii: S0167-8140(18)30017.
     PubMed     Abstract available
     
     
     
198. ADENIS A, Castan F, Conroy T
     Consolidation chemotherapy after definite concurrent chemoradiation in patients with non-operable esophageal cancer: Is it useful?
     Radiother Oncol. 2018 Jan 10. pii: S0167-8140(17)32773.
     PubMed    
     
     
     
199. CHEN Y, Wang J
     Concurrent chemoradiotherapy alone is feasible for esophageal squamous cell carcinoma patients not suitable for surgery.
     Radiother Oncol. 2018 Jan 10. pii: S0167-8140(17)32774.
     PubMed    
     
     
     
200. NEVENS D, Duprez F, Bonte K, Deron P, et al
     Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Reply to Elicin et al.
     Radiother Oncol. 2018 Jan 4. pii: S0167-8140(17)32770.
     PubMed    
     
     
     
201. GREGOIRE V, Evans M, Le QT, Bourhis J, et al
     Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Onc
     Radiother Oncol. 2018;126:3-24.
     PubMed     Abstract available
     
     
     
202. HANSEN CR, Johansen J, Samsoe E, Andersen E, et al
     Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy.
     Radiother Oncol. 2018;126:43-47.
     PubMed     Abstract available
     
     
     
203. LASSEN P, Lacas B, Pignon JP, Trotti A, et al
     Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
     Radiother Oncol. 2018;126:107-115.
     PubMed     Abstract available
     
     
     December 2017
204. ZHANG Y, Li WF, Liu X, Chen L, et al
     Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial.
     Radiother Oncol. 2017 Dec 16. pii: S0167-8140(17)32756.
     PubMed     Abstract available
     
     
     
205. SHIRAISHI Y, Fang P, Xu C, Song J, et al
     Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.
     Radiother Oncol. 2017 Dec 13. pii: S0167-8140(17)32751.
     PubMed     Abstract available
     
     
     
206. KAMAL M, Rosenthal DI, Volpe S, Goepfert RP, et al
     Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors.
     Radiother Oncol. 2017 Dec 8. pii: S0167-8140(17)32691.
     PubMed     Abstract available
     
     
     November 2017
207. LEE AW, Ng WT, Pan JJ, Poh SS, et al
     International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.
     Radiother Oncol. 2017 Nov 15. pii: S0167-8140(17)32686.
     PubMed     Abstract available
     
     
     
208. BOGOWICZ M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, et al
     Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
     Radiother Oncol. 2017 Nov 6. pii: S0167-8140(17)32663.
     PubMed     Abstract available
     
     
     
209. TAKAHASHI N, Umezawa R, Takanami K, Yamamoto T, et al
     Whole-body total lesion glycolysis is an independent predictor in patients with esophageal cancer treated with definitive chemoradiotherapy.
     Radiother Oncol. 2017 Nov 3. pii: S0167-8140(17)32659.
     PubMed     Abstract available
     
     
     October 2017
210. CEREDA E, Cappello S, Colombo S, Klersy C, et al
     Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy.
     Radiother Oncol. 2017 Oct 27. pii: S0167-8140(17)32655.
     PubMed     Abstract available
     
     
     
211. OU D, Garberis I, Adam J, Blanchard P, et al
     Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
     Radiother Oncol. 2017 Oct 24. pii: S0167-8140(17)32647.
     PubMed     Abstract available
     
     
     
212. DE-COLLE C, Menegakis A, Monnich D, Welz S, et al
     SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
     Radiother Oncol. 2017 Oct 20. pii: S0167-8140(17)32648.
     PubMed     Abstract available
     
     
     
213. RAO AD, Coquia S, De Jong R, Gourin C, et al
     Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancers.
     Radiother Oncol. 2017 Oct 3. pii: S0167-8140(17)32584.
     PubMed     Abstract available
     
     
     September 2017
214. MICHIELS S, Barragan AM, Souris K, Poels K, et al
     Patient-specific bolus for range shifter air gap reduction in intensity-modulated proton therapy of head-and-neck cancer studied with Monte Carlo based plan optimization.
     Radiother Oncol. 2017 Sep 23. pii: S0167-8140(17)32568.
     PubMed     Abstract available
     
     
     
215. WOPKEN K, Bijl HP, Langendijk JA
     Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: A systematic review of literature.
     Radiother Oncol. 2017 Sep 21. pii: S0167-8140(17)32545.
     PubMed     Abstract available
     
     
     
216. CHANG CL, Tsai HC, Lin WC, Chang JH, et al
     Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
     Radiother Oncol. 2017 Sep 15. pii: S0167-8140(17)32548.
     PubMed     Abstract available
     
     
     
217. SHIRAISHI Y, Xu C, Yang J, Komaki R, et al
     Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
     Radiother Oncol. 2017 Sep 13. pii: S0167-8140(17)32550.
     PubMed     Abstract available
     
     
     August 2017
218. 
     Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.
     Radiother Oncol. 2017;124:232-239.
     PubMed     Abstract available
     
     
     
219. MAVROIDIS P, Price A, Fried D, Kostich M, et al
     Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
     Radiother Oncol. 2017;124:240-247.
     PubMed     Abstract available
     
     
     
220. GUTTMANN DM, Frick MA, Carmona R, Deville C Jr, et al
     A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma.
     Radiother Oncol. 2017;124:271-276.
     PubMed     Abstract available
     
     
     June 2017
221. ZHANG W, Zhang X, Yang P, Blanchard P, et al
     Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
     Radiother Oncol. 2017;123:401-405.
     PubMed     Abstract available
     
     
     
222. CHEN AM, Chin R, Beron P, Yoshizaki T, et al
     Inadequate target volume delineation and local-regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer.
     Radiother Oncol. 2017;123:412-418.
     PubMed     Abstract available
     
     
     April 2017
223. WU B, Kusters M, Kunze-Busch M, Dijkema T, et al
     Cross-institutional knowledge-based planning (KBP) implementation and its performance comparison to Auto-Planning Engine (APE).
     Radiother Oncol. 2017;123:57-62.
     PubMed     Abstract available
     
     
     March 2017
224. NAKAMURA N, Zenda S, Tahara M, Okano S, et al
     Proton beam therapy for olfactory neuroblastoma.
     Radiother Oncol. 2017;122:368-372.
     PubMed     Abstract available
     
     
     February 2017
225. HAMMING-VRIEZE O, van Kranen SR, Heemsbergen WD, Lange CA, et al
     Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy.
     Radiother Oncol. 2017;122:224-228.
     PubMed     Abstract available
     
     
     
226. SODERSTROM K, Nilsson P, Laurell G, Zackrisson B, et al
     Dysphagia - Results from multivariable predictive modelling on aspiration from a subset of the ARTSCAN trial.
     Radiother Oncol. 2017;122:192-199.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: